• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

Advertisement

Product › Details

MALDI Biotyper system

Photo and link provided and sponsored by Bruker Daltonik GmbH, Bremen, Germany

	Next higher product group	MALDI-TOF mass spectrometer
	Status	2006-01-01 sales start
	Organisation	Bruker Daltonics (Group)
	Today	Bruker Corporation (Group)
	Group	Bruker Corporation (Group)

Bruker Daltonics. (5/18/09). "Press Release: Bruker Announces U.S. Collaborations for the Clinical Validation of Rapid Highly Specific and Low-Cost Microbial Identification by Proteomic Fingerprinting Using its MALDI Biotyper". Philadelphia.

At the 109th General Meeting of the American Society for Microbiology, Bruker Daltonics announced collaborations in the United States for the clinical validation of its MALDI Biotyper workflow for microorganism identification. The MALDI Biotyper has recently obtained the IVD-CE Mark, and is currently for Research Use Only (RUO) outside of the European Union.

The MALDI Biotyper is a rapid, mass spectrometry based platform for identifying bacteria, yeasts and fungi. A high-quality, well-curated database with entries from over 3,000 strains cover approximately 2,000 well-characterized microbial species. Starting from a cultured colony, the identification is performed by matching the measured protein fingerprint against the proprietary MALDI Biotyper database. Including the database search, the automatic identification is performed in minutes, multiple colonies can be spotted on a single target, and about 30-60 identifications an hour can be performed for high throughput. The MALDI Biotyper specificity of identification is very high and comparable to DNA sequencing, false positive rates are near zero, mass spectrometry experience is not required and the consumables cost per sample is very low.

In Europe, Bruker has installed over 40 MALDI Biotyper instruments in routine laboratories for clinical microbiology, and the MALDI Biotyper is rapidly becoming a new standard for robust, rapid microbial identification. Recently, in the United States several collaborations have been initiated to validate the MALDI Biotyper for clinical usage. The Microbiology Service of the NIH Clinical Center in Bethesda, MD has performed extensive studies using the MALDI Biotyper for identification of yeasts and bacteria. Their tests have shown advantages in cost, speed, and accuracy compared with conventional biochemical testing and gene sequencing, methods routinely used in their lab. The collaboration with the NIH group is currently focused on expanding the database for identification of mycobacteria, nocardia and filamentous yeasts.

In addition, larger scale clinical research studies are also underway at the microbiology departments of two major U.S. medical school hospitals, and results from those studies are expected in 2009.

ABOUT BRUKER DALTONICS

For more information about Bruker Daltonics and Bruker Corporation (NASDAQ: BRKR), please visit www.bdal.com and www.bruker.com.

Bruker Daltonics
Darwin Asa, Ph.D., +1 978-663-3660, ext. 1149
Life-Science Marketing Manager,
dja@bdal.com

Record changed: 2012-04-02

More documents for MALDI Biotyper system

• [1] Bruker Corporation. (3/31/12). "Press Release: Bruker Expands MALDI Biotyper Capabilities with New Protocols and Reference Libraries for Myobacteria and Multicellilar Fungi". London....
• [2] Bruker Corporation. (3/31/12). "Press Release: Bruker and University Medical Center Groningen (UMCG) Announce a Collaboration within New European Network for Rapid Identification of Anaerobes (ENRIA)". London....
• [3] Quotient Bioresearch Ltd.. (9/19/11). "Press Release: Quotient Bioresearch Announces First Use of Bruker MALDI Biotyper for Bacterial Identification"....
• [4] Bruker Corporation. (6/27/11). "Press Release: Bruker and Francisco Soria Melguizo S.A. Expand Their Exclusive Agreement for Distribution of th MALDI Biotyper to Cover Spain and Portugal". Geneva....
• [5] Bruker Corporation. (6/27/11). "Press Release: Bruker and the Institute of Medical Microbiology at the University of Zurich Announce a Collaboration for Mass Spectrometry-based Microbial Identification". Geneva....
• [6] Bruker Corporation. (6/27/11). "Press Release: Laboratory Viollier Extends the Business Relationship with Bruker Concerning MALDI Biotyper System for Mass Spectrometry-based Microbial Identification". Geneva....
• [7] Shaffer, Catherine. (5/15/11). "News: Mass Spec Makes Its Way into the Clinic. Out-of-the-Box Solutions Ease Transition by Lowering Costs and Improving User Friendliness"....
• [8] Bruker Corporation. (5/8/11). "Press Release: Bruker Announces Integrated Microbiology Workflow for MALDI Biotyper Microbial Identification and BD Phoenix Antibiotic Susceptibility Testing". Milano....
• [9] Bruker Corporation. (5/7/11). "Press Release: Bruker Introduces New Consumable MALDI Biotarget for the MALDI Biotyper Workflow Using Proteomic Microbial Identification". Milano....
• [10] Bruker Corporation. (4/7/11). "Press Release: Bruker’s IVD MALDI Biotyper Now Available to Clinical Microbiology Sites in Canada for Proteomic Identification of Microorganisms"....

To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2012. Made in Germany.